Export terminé — 

Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: Protocol

BACKGROUND: Warfarin and similar vitamin K antagonists have been the standard therapy for patients with mechanical or biological valve prosthesis and atrial fibrillation (AF). Even with the appropriate use of therapy, some studies have reported that there is a high incidence of thromboembolic events...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Duraes, Andre Rodrigues, Roriz, Pollianna DS, Bulhoes, Fabio V, Nunes, Bianca DA, Muniz, Juliana QV, Neto, Italvar NDCR, Fernandes, Andre MS, Reis, Francisco JFBD, Camara, Edmundo JN, Junior, Erenaldo DSR, Segundo, Deusdeth TS, Silva, Felipe Pinho E Albuquerque, Aras, Roque
Format: Artigo
Langue:Inglês
Publié: JMIR Publications Inc. 2014
Sujets:
Protocol
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004148/
https://ncbi.nlm.nih.gov/pubmed/24691436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/resprot.3014
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires